Showing 9 of 9 recruiting trials for “Diffuse large B-cell lymphoma with chronic inflammation”
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
👨⚕️ Amanda F Cashen, M.D., Washington University School of Medicine📍 1 site📅 Started Jan 2025View details ↗
Pola-ZR2P in Previously Untreated DLBCL
RecruitingNCT06755775 ↗
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
👨⚕️ Caspian Oliai, MD, UCLA / Jonsson Comprehensive Cancer Center📍 3 sites📅 Started Jan 2023View details ↗
Pro-miniCHOP-like Regimen for Treatment-naive Elderly Patients
R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
👨⚕️ Mats Jerkeman, Department of Oncology, Skåne University Hospital📍 69 sites📅 Started Aug 2020View details ↗
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →